XERIS BIOPHARMA HOLDINGS, INC. (XERS) Free cash flow 2020–2021
XERIS BIOPHARMA HOLDINGS, INC. (XERS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$96.6MFY2021 · since FY2020: -$80.9M → -$96.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -$96.6M | -19.4% |
| FY2020 | -$80.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More XERS financial trends
XERS RevenueXERS Net incomeXERS Net marginXERS Gross profitXERS Gross marginXERS Operating incomeXERS Operating marginXERS Operating cash flowXERS Capital expendituresXERS Return on equityXERS Stock buybacksXERS Dividends paidXERS Total assetsXERS Total liabilitiesXERS Shareholders’ equityXERS overview →